As venture capital remains difficult to reach, the availability of debt financing, royalty financing, family office funding, and other alternative methods, as well as PIPEs for public companies, become more attractive options. This panel of deal makers will share lessons learned on prioritizing and pursuing alternative funding sources.
Speakers:
- Daniel L. Forman, Partner, Lowenstein Sandler LLP
- Chris Chen, Partner, Strategic Investment Fund, Gates Foundation
- Lucas de Breed, Director, Investments, BrightEdge, American Cancer Society
- Brienne Kugler, Senior Vice President, Research & Investments, Royalty Pharma
- Thomas Hoffmann, Head of Institutional Equities & Corporate Access, H.C. Wainwright & Co., LLC
Moderator:
- Jeff Raphael, Managing Partner, Life Sciences Strategic Advisory, OmniScope Partners
Time: 11-11:50 a.m. ET
Location: The New York Marriott Marquis, 1535 Broadway, New York, NY 10036
*Disclaimer: This event is open to the public but requires a registration fee.
